Marshall Wace, LLP Ideaya Biosciences, Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 252,305 shares of IDYA stock, worth $6.35 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
252,305
Previous 98,811
155.34%
Holding current value
$6.35 Million
Previous $3.47 Million
130.41%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding IDYA
# of Institutions
215Shares Held
80.8MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$171 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$131 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$130 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$121 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$101 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.21B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...